Literature DB >> 20386631

Is seroquel developing an illicit reputation for misuse/abuse?

Randy A Sansone1, Lori A Sansone.   

Abstract

Quetiapine, an atypical antipsychotic, has been the subject of a series of case reports that suggest a potential for misuse/abuse. The available cases indicate a male predominance; oral, intranasal, or intravenous routes of administration; misuse/abuse in jail or inpatient psychiatric settings; and subjects with extensive histories of polysubstance abuse. While possible pharmacological explanations have been proffered, compared to the other atypical antipsychotics, there is no clear explanation for an alleged higher risk of misuse/abuse with quetiapine. Likewise, there are no available animal or human empirical studies to evaluate risk. At this juncture, clinicians in psychiatric and primary care settings can only remain alert to a potential risk, particularly in patients who meet the current demographic profile.

Entities:  

Keywords:  Quetiapine; abuse; misuse

Year:  2010        PMID: 20386631      PMCID: PMC2848462     

Source DB:  PubMed          Journal:  Psychiatry (Edgmont)        ISSN: 1550-5952


  25 in total

1.  Intranasal quetiapine abuse.

Authors:  Joseph M Pierre; Igor Shnayder; Donna A Wirshing; William C Wirshing
Journal:  Am J Psychiatry       Date:  2004-09       Impact factor: 18.112

Review 2.  Modern antipsychotic drugs: a critical overview.

Authors:  David M Gardner; Ross J Baldessarini; Paul Waraich
Journal:  CMAJ       Date:  2005-06-21       Impact factor: 8.262

Review 3.  Strategies for maximizing clinical effectiveness in the treatment of schizophrenia.

Authors:  Rajiv Tandon; Steven D Targum; Henry A Nasrallah; Ruth Ross
Journal:  J Psychiatr Pract       Date:  2006-11       Impact factor: 1.325

4.  Quetiapine: another drug with potential for misuse? A case report.

Authors:  Thomas Paparrigopoulos; Dimitris Karaiskos; John Liappas
Journal:  J Clin Psychiatry       Date:  2008-01       Impact factor: 4.384

5.  Low-dose quetiapine is not a benign sedative-hypnotic agent.

Authors:  James J Gugger; Manouchkathe Cassagnol
Journal:  Am J Addict       Date:  2008 Sep-Oct

6.  Possible intranasal quetiapine misuse.

Authors:  Anna K Morin
Journal:  Am J Health Syst Pharm       Date:  2007-04-01       Impact factor: 2.637

7.  Potential benefits of quetiapine in the treatment of substance dependence disorders.

Authors:  S Pirzada Sattar; Subhash C Bhatia; Frederick Petty
Journal:  J Psychiatry Neurosci       Date:  2004-11       Impact factor: 6.186

8.  Additional evidence of the abuse potential of quetiapine.

Authors:  Roy R Reeves; James C Brister
Journal:  South Med J       Date:  2007-08       Impact factor: 0.954

9.  Quetiapine for the treatment of cocaine dependence: an open-label trial.

Authors:  Annette Kennedy; Amanda Ernst Wood; Andrew J Saxon; Carol Malte; Megan Harvey; Jennifer Jurik; Nael Kilzieh; Cassin Lofgreen; Andre Tapp
Journal:  J Clin Psychopharmacol       Date:  2008-04       Impact factor: 3.153

10.  Quetiapine decreases alcohol consumption, craving, and psychiatric symptoms in dually diagnosed alcoholics.

Authors:  G Martinotti; S Andreoli; M Di Nicola; M Di Giannantonio; M Sarchiapone; L Janiri
Journal:  Hum Psychopharmacol       Date:  2008-07       Impact factor: 1.672

View more
  12 in total

Review 1.  Use of quetiapine in children and adolescents.

Authors:  Gabriele Masi; Annarita Milone; Stefania Veltri; Raffaella Iuliano; Chiara Pfanner; Simone Pisano
Journal:  Paediatr Drugs       Date:  2015-04       Impact factor: 3.022

2.  The toxicology and comorbidities of fatal cases involving quetiapine.

Authors:  Jennifer L Pilgrim; Olaf H Drummer
Journal:  Forensic Sci Med Pathol       Date:  2013-02-09       Impact factor: 2.007

Review 3.  Concerns about quetiapine.

Authors:  Jonathan Brett
Journal:  Aust Prescr       Date:  2015-06-01

4.  Deep pharma: psychiatry, anthropology, and pharmaceutical detox.

Authors:  Michael Oldani
Journal:  Cult Med Psychiatry       Date:  2014-06

5.  Emergency Department Visits Involving Misuse and Abuse of the Antipsychotic Quetiapine: Results from the Drug Abuse Warning Network (DAWN).

Authors:  Margaret E Mattson; Victoria A Albright; Joanna Yoon; Carol L Council
Journal:  Subst Abuse       Date:  2015-05-24

6.  Intentional Recreational Abuse of Quetiapine Compared to Other Second-generation Antipsychotics.

Authors:  Lauren Klein; Stacey Bangh; Jon B Cole
Journal:  West J Emerg Med       Date:  2016-12-06

7.  Dependence potential of quetiapine: behavioral pharmacology in rodents.

Authors:  Hye Jin Cha; Hyun-A Lee; Joon-Ik Ahn; Seol-Hee Jeon; Eun Jung Kim; Ho-Sang Jeong
Journal:  Biomol Ther (Seoul)       Date:  2013-07-30       Impact factor: 4.634

8.  Acute dyskinesia, myoclonus, and akathisa in an adolescent male abusing quetiapine via nasal insufflation: a case study.

Authors:  Mathew George; Maya Haasz; Alvaro Coronado; Steven Salhanick; Lindsey Korbel; Joseph P Kitzmiller
Journal:  BMC Pediatr       Date:  2013-11-16       Impact factor: 2.125

9.  Social Media Mining for Toxicovigilance: Automatic Monitoring of Prescription Medication Abuse from Twitter.

Authors:  Abeed Sarker; Karen O'Connor; Rachel Ginn; Matthew Scotch; Karen Smith; Dan Malone; Graciela Gonzalez
Journal:  Drug Saf       Date:  2016-03       Impact factor: 5.606

Review 10.  Abuse of Prescription Drugs in the Context of Novel Psychoactive Substances (NPS): A Systematic Review.

Authors:  Fabrizio Schifano; Stefania Chiappini; John M Corkery; Amira Guirguis
Journal:  Brain Sci       Date:  2018-04-22
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.